NADAL® Nuclear Matrix Protein 22 Test

Clinical Laboratory

NADAL® Nuclear Matrix Protein 22 Test 562011N-10

nal von Minden · 562011N-10

Article No. AK-CL-458

Product details

Article number
AK-CL-458
Category
Clinical Laboratory
Brand
nal von Minden
Model
562011N-10

Description

The NADAL® Nuclear Matrix Protein 22 (NMP22) Test from nal von Minden is a reliable in-vitro immunoassay for the qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA) in urine. This professional rapid test offers doctors a simple and hygienic method for bladder cancer screening and monitoring, with results available in approximately 15 minutes. To obtain data on diagnostic sensitivity and specificity, urine from 32 patients with biopsy-confirmed bladder cancer and 112 healthy individuals without bladder tumours was tested with the NADAL® Nuclear Matrix Protein 22 Test. The results are shown in the table below:

Request a quotation

Equipment standard by AKLION — configuration, accessories and lead time are confirmed on the quotation.

Technical specifications

Brand
nal von Minden
Model
562011N-10
Product type
Point Of Care Testing Devices
Sample material
Urine
Detected parameter
Nuclear Matrix Protein 22